Merck Serono News
Most Popular Merck Serono Story
Merck Serono, Theratechnologies ink $215M deal
Merck Serono has signed a deal to license the U.S. commercialization right to tesamorelin, a drug to treat excess abdominal fat in HIV patients with lipodystrophy. Theratechnologies retains rights to Read more...
Latest Headlines
- October 28, 2011
- October 21, 2011
- September 7, 2011
- September 2, 2011
- January 18, 2011
- November 4, 2010
- September 28, 2009
- May 12, 2009
- March 23, 2009
- January 13, 2009
- October 29, 2008
- September 4, 2008
- June 18, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
